Evidence map›Paper›PMID 42654740›Full record

ArticlePathogens (Basel, Switzerland)2026

Development and Analytical Validation of a Multiplex Real-Time RT-PCR Assay for Simultaneous Detection of Avian Influenza A Virus and Newcastle Disease Virus.

Yerbol Burashev, Saken Khaidarov, Nurdos A Aubakir, Zamira D Omarova, Ali B Tulendibayev, Takhmina U Argimbayeva, Tangat T Yermekbay, Khairulla B Abeuov, Rashida A Rystaeva, Kulyaisan T Sultankulova and 6 more

Abstract readValidation Study
In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yerbol BurashevResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-4701-1992
Saken KhaidarovDepartment of Molecular Biology and Medical Genetics, Kazakh National Medical University named after S.D. Asfendiyarov, Zheltoksan 37A Street, Almaty 050012, Kazakhstan.ORCID 0000-0001-7770-8427
Nurdos A AubakirResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.
Zamira D OmarovaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.
Ali B TulendibayevResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.
Takhmina U ArgimbayevaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.
Tangat T YermekbayResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.
Khairulla B AbeuovResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.
Rashida A RystaevaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.
Kulyaisan T SultankulovaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.
Sabit K KokanovResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.
Nurlan S KozhabergenovResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0001-6299-9399
Gaukhar O ShynybekovaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-6976-1540
Sergazy Sh NurabayevResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.
Kuandyk ZhugunissovResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0003-4238-5116
Mukhit B OrynbayevResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Ministry of Health Care of the Republic of Kazakhstan, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-5882-4964

Funding

This research was funded by the Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan AP19676553 "Epidemiological monitoring and development of modern diagnostic tools for particularly dangerous viral diseases of birds"
6 · The paper itself

Abstract

Avian influenza A virus (AIV) and Newcastle disease virus (NDV) are among the most damaging pathogens of poultry, and AIV also carries zoonotic potential that places it within the One Health agenda. The two infections frequently produce overlapping clinical signs, so a method that detects both in a single reaction has clear practical value for surveillance. We developed a duplex one-step real-time reverse-transcription PCR (RT-qPCR) that detects AIV in the FAM channel and NDV in the ROX channel. Primers and hydrolysis probes were designed against conserved regions of the AIV nucleoprotein and matrix genes and the NDV matrix, phosphoprotein and nucleoprotein genes, after alignment of 500 sequences per virus retrieved from GenBank from different geographic regions. Annealing temperature, primer and probe concentrations were optimised, and recombinant plasmids carrying the target fragments served both as positive controls and as quantitative standards. The assay was specific for AIV and NDV, with no cross-reactivity with infectious bronchitis virus and no signal crossover between channels; its analytical sensitivity reached approximately 10-20 RNA copies per reaction. Qualitative results on reference isolates were fully concordant with two commercial veterinary kits (Cohen's κ = 1.00), and the assay passed inter-laboratory commission testing. This study establishes the design and core analytical performance of a laboratory-developed duplex assay; expanded in silico inclusivity on contemporary sequences, a broader specificity panel, inhibitor-containing matrices, an internal amplification control, and prospective clinical validation are required before routine surveillance deployment.

Indexed as

Influenza A virusInfluenza in BirdsMultiplex Polymerase Chain ReactionNewcastle DiseaseNewcastle disease virusReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionAnimalsBirdsDNA PrimersSensitivity and SpecificityDNA Primersanalytical validationavian influenza A virusin silico specificitylimit of detectionmolecular diagnosticsmultiplex real-time RT-PCRNewcastle disease virusOne Healthpathogen surveillancepoultry

Identifiers

PMID42654740
PMCPMC13516808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.